...
首页> 外文期刊>European journal of pharmaceutical sciences >Hot melt extrusion technology for improved dissolution, solubility and 'spring-parachute' processes of amorphous self-micellizing solid dispersions containing BCS II drugs indomethacin and fenofibrate: Profiles and mechanisms
【24h】

Hot melt extrusion technology for improved dissolution, solubility and 'spring-parachute' processes of amorphous self-micellizing solid dispersions containing BCS II drugs indomethacin and fenofibrate: Profiles and mechanisms

机译:热熔挤出技术,用于改进溶解,溶解度和“弹簧降落伞”的无定形自晶体胶束固体分散体的过程,含有BCS II药物Indomethacin和Fenofibrate:曲线和机制

获取原文
获取原文并翻译 | 示例
           

摘要

Many strategies have been employed to improve oral drug delivery. One such approach involves the use of supersaturable delivery systems such as amorphous self-micellizing solid dispersions (SmSDs). SmSDs have attracted more attention recently, but little is known regarding the impact of production methods on profiles and internal mechanisms of final SmSDs in spite of its importance. In this study, amorphous SmSDs containing selfmicellizing Soluplus (R) and BCS II drug (either indomethacin (IND) or fenofibrate (FEN)) were generated using various methods: solvent evaporation (SOL), freeze-drying (FD), microwave radiation-quench cooling (MQC), and hot melt extrusion (HME). Microscopic morphology, amorphous state, thermal behavior, dissolution/solubility, and "spring-parachute" data were used to assemble physicochemical profiles for SmSD systems prepared using each method. Analysis of intermolecular interactions, solubilization, and crystallization inhibition further uncovered internal mechanisms explaining observed physicochemical properties. Generally, SmSD/IND and SmSD/FEN systems generated using HME exhibited superior dissolution, solubility, and spring-parachute profiles. The superior advantages of HME-generated SmSD/IND systems were attributed to relatively stronger intermolecular interactions than observed in SmSD/IND systems fabricated using other methods. Moreover, selfmicellizing Soluplus (R) carrier was able to solubilize IND or FEN and suppress drug crystallization from a supersaturated state, which seemed to be an important mechanism for the properties enhancement caused by SmSD/FEN HME . This knowledge should be useful for guiding further development of self-micellizing solid dispersions and for gaining deeper understanding of how HME technology can improve supersaturable drug delivery based on SmSDs strategy.
机译:已经采用了许多策略来改善口服药物递送。一种这样的方法涉及使用诸如无定形自晶纤维化固体分散体(SMSD)的可饱和递送系统。最近,SMSD已经吸引了更多的关注,但是对于生产方法对最终SMSD的谱和内部机制的影响很少,尽管重要的是。在本研究中,使用各种方法产生含有自炼酸溶胶(R)和BCS II药物(吲哚美辛(IND)或芬福纤维(FEN))的无定形SMSD:溶剂蒸发(溶胶),冷冻干燥(FD),微波辐射 - 淬火冷却(MQC)和热熔挤出(HME)。微观形态,无定形状态,热行为,溶解/溶解度和“弹簧降落伞”数据用于组装使用每种方法制备的SMSD系统的物理化学曲线。分子间相互作用,溶解和结晶抑制的分析进一步揭示了观察到的物理化学性质的内部机制。通常,使用HME产生的SMSD / IND和SMSD / FEN系统表现出优异的溶解,溶解度和弹簧降落伞。 HME - 生成的SMSD / Ind系统的优异优势归因于使用其他方法制造的SMSD / IND系统中观察到的相对较强的分子间相互作用。此外,Selficellizing Soluplus(R)载体能够溶解IND或FEN并抑制来自过饱和状态的药物结晶,这似乎是SMSD / FEN HME引起的性能增强的重要机制。这种知识对于引导自晶纤维化固体分散体的进一步发展是有用的,并且可以更深入地了解HME技术如何根据SMSDS策略改善可超出可抵抗的药物递送。

著录项

相似文献

  • 外文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号